Company: PETVW
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023398
Chunk: 41

Company: PetVivo Holdings, Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 41
---
 and equine lameness related to or due to synovial
joint issues.

We
commenced sales of Spryng® in the second quarter of fiscal 2022 and plan to increase our commercialization efforts of Spryng®
in the United States through our distribution relationship with MWI Veterinary Supply Co. (“Distributor” or “MWI”), Vedco, Inc.
and the use of sales reps, clinical studies, and market awareness to educate and inform key opinion leaders on the benefits of Spryng®.

VetStem,
Inc.

On
February 14, 2025, the “Company” and VetStem, Inc. (“VetStem”) entered into an Exclusive
License and Supply Agreement pursuant to which VetStem will license to us, on an exclusive basis, the right to sell, have sold, offer
for sale and import Therapeutic Compositions and Products involving PrecisePRP™ equine and PrecisePRP™ canine. Exclusivity
shall be maintained as long as the mutually agreed upon annual minimum purchases of Products are made during the first five years of
the Agreement, with an option to extend exclusivity upon the mutual agreement of the Parties.

VetStem,
Inc. is a veterinarian-led company established in 2002 to bring regenerative medicine to the veterinary profession. Based near San Diego,
California, this privately held biopharmaceutical enterprise offers veterinarians a range of regenerative modalities, including autologous
stem cell processing from patients’ own fat tissue. With over 15 years of expertise and thousands of treatments for joint, tendon,
and ligament issues, VetStem has made regenerative medicine a therapeutic reality. The VetStem team is dedicated to developing clinically
practical and affordable solutions that harness the natural restorative abilities of living organisms. In addition to its own patents,
VetStem holds exclusive global veterinary licenses to a significant portfolio of patents in regenerative medicine and is in the late
stages of approval of additional regenerative medicine solutions for the veterinarian.

PrecisePRP™ is
a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. It is a leucoreduced, allogeneic,
pooled, freeze-dried PRP intended to provide a species-specific source of concentrated platelets in plasma for intra-articular administration
in dogs and horses. Unlike any PRP mechanical kits currently on the market. Prec